Cannabis News

The cannabis industry in the United States is undergoing a period of historic change. From new state legalization ballot measures to ongoing federal rescheduling efforts, the regulatory environment shifts constantly. Staying up to date with accurate, unbiased cannabis news has never been more important for patients, consumers, business owners, and advocates. Leefii provides daily coverage of these developments, curated from trusted sources and organized for quick consumption.

On the federal front, the Drug Enforcement Administration and Department of Health and Human Services continue to evaluate cannabis scheduling under the Controlled Substances Act. Rescheduling or descheduling cannabis would have massive implications for banking, taxation, interstate commerce, and criminal justice reform. At the same time, Congress considers legislation like the SAFE Banking Act that would give cannabis businesses access to traditional financial services, reducing the risks of operating in a cash-heavy industry.

At the state level, the landscape varies dramatically. States like California, Colorado, and Oregon have mature recreational markets with hundreds of licensed dispensaries. Meanwhile, states such as Florida, Ohio, and Pennsylvania are expanding their medical cannabis programs and considering adult-use legalization. Some states remain prohibition-only, though even these are seeing legislative proposals introduced each session. Leefii tracks all of these developments and connects the news to our comprehensive state cannabis law guides and dispensary directory.

Beyond policy, the cannabis industry is a rapidly growing economic sector. Market research firms project the U.S. legal cannabis market will generate tens of billions of dollars in annual revenue, supporting hundreds of thousands of jobs in cultivation, manufacturing, retail, and ancillary services. Leefii covers dispensary openings, mergers and acquisitions, public company earnings, and emerging trends like cannabis beverages, nano-emulsion technology, and craft cannabis brands.

Scientific research on cannabis is also accelerating. Universities and research institutions are publishing studies on cannabinoids, terpenes, the endocannabinoid system, and the therapeutic potential of cannabis for conditions ranging from chronic pain and epilepsy to anxiety and PTSD. We report on these findings in our science category, translating complex research into accessible summaries that help readers make informed decisions about their health and wellness.